• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本无脉络膜症患者的REP-1基因突变

REP-1 gene mutations in Japanese patients with choroideremia.

作者信息

Fujiki K, Hotta Y, Hayakawa M, Saito A, Mashima Y, Mori M, Yoshii M, Murakami A, Matsumoto M, Hayasaka S, Tagami N, Isashiki Y, Ohba N, Kanai A

机构信息

Department of Ophthalmology, Juntendo University School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan,

出版信息

Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):735-40. doi: 10.1007/s004170050305.

DOI:10.1007/s004170050305
PMID:10447648
Abstract

BACKGROUND

Choroideremia (CHM) is an X-linked progressive dystrophy of the choroid, retinal pigment epithelium, and retina. Recently, the REP-1 gene was isolated and the causative mutations in the gene were detected in patients with CHM. In a previous study, we described a Japanese family with CHM who had a mutation in the REP-1 gene. In the present study, we performed extensive analysis of the REP-1 gene in patients with CHM from several institutions in Japan.

METHODS

Twenty-six patients with CHM and 5 unaffected females from 22 independently ascertained families were examined. Exons 1-15 of the REP-1 gene were screened by single-strand conformation polymorphism. The DNA fragments suspected of any variations were directly sequenced.

RESULTS

Fifteen different mutations, including one previously reported mutation, were detected in 18 families. In addition, carrier status was proven in four unaffected females found to be heterozygous for the mutant allele.

CONCLUSIONS

Fifteen different mutations of the REP-1 gene were detected in 18 Japanese families. There were no hot spots for the mutations and no missense mutations. The results show that REP-1 gene defects cause CHM in Japanese patients, and the mutations in these Japanese patients differed from the mutations reported for CHM patients in Europe, Canada, and America except for R267X and 1313delTC. These findings suggest that the mutations occurred independently in the Japanese patients.

摘要

背景

无脉络膜症(CHM)是一种X连锁的脉络膜、视网膜色素上皮和视网膜进行性营养不良疾病。最近,REP - 1基因被分离出来,并且在无脉络膜症患者中检测到该基因的致病突变。在之前的一项研究中,我们描述了一个患有CHM的日本家族,其REP - 1基因存在突变。在本研究中,我们对来自日本多个机构的CHM患者的REP - 1基因进行了广泛分析。

方法

对来自22个独立确定的家族的26例CHM患者和5名未受影响的女性进行了检查。通过单链构象多态性对REP - 1基因的外显子1 - 15进行筛查。对怀疑有任何变异的DNA片段进行直接测序。

结果

在18个家族中检测到15种不同的突变,其中包括1种先前报道的突变。此外,在4名未受影响的女性中证实了携带状态,她们被发现为突变等位基因的杂合子。

结论

在18个日本家族中检测到REP - 1基因的15种不同突变。这些突变没有热点,也没有错义突变。结果表明,REP - 1基因缺陷导致日本患者患CHM,除了R267X和1313delTC外,这些日本患者的突变与欧洲、加拿大和美国报道的CHM患者的突变不同。这些发现表明这些突变在日本患者中是独立发生的。

相似文献

1
REP-1 gene mutations in Japanese patients with choroideremia.日本无脉络膜症患者的REP-1基因突变
Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):735-40. doi: 10.1007/s004170050305.
2
Visual impairment and REP-1 gene mutations in Japanese choroideremia patients.日本无脉络膜症患者的视力损害与REP-1基因突变
Ophthalmic Genet. 1999 Jun;20(2):107-15. doi: 10.1076/opge.20.2.107.2285.
3
A practical diagnostic test for choroideremia.一种用于诊断脉络膜视网膜萎缩的实用检测方法。
Ophthalmology. 1998 Sep;105(9):1637-40. doi: 10.1016/S0161-6420(98)99031-5.
4
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.无脉络膜症(CHM)的分子基础:涉及Rab护送蛋白1(REP-1)基因的突变
Hum Mutat. 1997;9(2):110-7. doi: 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2-D.
5
A hemizygous A to CC base change of the CHM gene causing choroideremia associated with pinealoma.
Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):653-5. doi: 10.1007/BF00946942.
6
Mutation analysis in Canadian families with choroideremia.
Ophthalmic Genet. 1996 Jun;17(2):47-52. doi: 10.3109/13816819609057870.
7
Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients.
Hum Mol Genet. 1994 Jul;3(7):1047-51. doi: 10.1093/hmg/3.7.1047.
8
Novel types of mutation in the choroideremia ( CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon.脉络膜营养不良(CHM)基因的新型突变类型:全长L1插入和激活一个隐匿外显子的内含子突变。
Hum Genet. 2003 Aug;113(3):268-75. doi: 10.1007/s00439-003-0970-0. Epub 2003 Jun 25.
9
Clinical features of Japanese families with a 402delT or a 555-556delAG mutation in choroideremia gene.患有脉络膜营养不良基因402delT或555 - 556delAG突变的日本家庭的临床特征。
Retina. 2004 Dec;24(6):940-5. doi: 10.1097/00006982-200412000-00015.
10
Altered rep-1 expression due to substitution at position +3 of the IVS13 splice-donor site of the choroideremia (CHM) gene.
Curr Eye Res. 1998 Jul;17(7):726-9.

引用本文的文献

1
Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers.女性脉络膜视网膜病变携带者的视网膜营养不良和视网膜下类玻璃膜疣沉积物
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2099-2111. doi: 10.1007/s00417-017-3751-5. Epub 2017 Jul 27.
2
The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype.脉络膜缺损中CHM基因突变谱及其与临床表型的关系。
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6033-6039. doi: 10.1167/iovs.16-20230.
3
Next-generation sequencing-based molecular diagnosis of 35 Hispanic retinitis pigmentosa probands.
基于下一代测序的 35 名西班牙裔色素性视网膜炎先证者的分子诊断。
Sci Rep. 2016 Sep 6;6:32792. doi: 10.1038/srep32792.
4
Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy.对一个大型脉络膜营养不良数据集的分析并不表明在未来的基因治疗试验中倾向于纳入某些基因型。
Mol Genet Genomic Med. 2016 Feb 28;4(3):344-58. doi: 10.1002/mgg3.208. eCollection 2016 May.
5
Recent advances and future prospects in choroideremia.脉络膜缺损的最新进展与未来展望
Clin Ophthalmol. 2015 Nov 23;9:2195-200. doi: 10.2147/OPTH.S65732. eCollection 2015.
6
Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia.基于下一代测序技术的无脉络膜症分子诊断
Case Rep Ophthalmol. 2015 Jul 25;6(2):246-50. doi: 10.1159/000437348. eCollection 2015 May-Aug.
7
Pathogenic mechanisms and the prospect of gene therapy for choroideremia.视网膜色素变性的致病机制及基因治疗前景
Expert Opin Orphan Drugs. 2015 Jul 1;3(7):787-798. doi: 10.1517/21678707.2015.1046434.
8
Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia.三个患有脉络膜骨瘤的中国内地家庭的遗传和表型特征
Mol Vis. 2012;18:309-16. Epub 2012 Feb 3.
9
microRNAs and genetic diseases.微小RNA与遗传疾病
Pathogenetics. 2009 Nov 4;2(1):7. doi: 10.1186/1755-8417-2-7.
10
A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings.在一个日本家族中发现的脉络膜营养不良基因的一种新型突变(967-970+2)delAAAGGT及相关临床发现。
Jpn J Ophthalmol. 2008 Jul-Aug;52(4):289-297. doi: 10.1007/s10384-008-0564-4. Epub 2008 Sep 5.